Inozyme Pharma, Inc.

NASDAQ:INZY

0.9997 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182001
Operating Activities:
Net Income -102.024-71.169-67.061-56.624-56.424-19.724-6.9640
Depreciation & Amortization -4.2970.8330.7440.6740.2170.0830.0260
Deferred Income Tax 0000.170000
Stock Based Compensation 7.9457.0377.6727.1642.3080.3010.4440
Change In Working Capital 4.714-3.0822.0120.085-0.1110.6011.4310
Accounts Receivables 00000000
Inventory 00000000
Accounts Payables 1.364-1.3780.15-0.6752.098-0.0830.8020
Other Working Capital 3.35-1.7041.8620.76-2.2090.6840.6290
Other Non Cash Items 1.755-4.294-1.1280.37818.036-0.071-4.3740
Operating Cash Flow -91.907-70.675-57.761-48.153-35.974-18.81-9.4370
Investing Activities:
Investments In Property Plant And Equipment -0.062-0.298-0.41-0.397-0.568-0.139-0.2590
Acquisitions Net 000.005-0.0430.1170.00800
Purchases Of Investments -155.052-269.33-151.993-121.967-177.922-24.662-13.5680
Sales Maturities Of Investments 222.112215.982147165.1661.31116.4122.8330
Other Investing Activites 00-0.0050.043-0.117-0.0089.2650
Investing Cash Flow 66.998-53.646-5.40342.796-117.179-8.3919.0060
Financing Activities:
Debt Repayment 0404.0500000
Common Stock Issued 10.52185.64756.1370.609115.97222.9731.9450
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 0.8770.32212.6010.60933.8422.9731.9450
Financing Cash Flow 11.398125.96972.7880.609149.81222.9731.9450
Other Information:
Effect Of Forex Changes On Cash 0.004-0.018-0.0250.0240000
Net Change In Cash -13.5071.639.599-4.724-3.341-4.23131.5140
Cash At End Of Period 21.39234.89933.26923.6728.39431.73535.9660